Abstract
Objetivo
Describir el tratamiento inicial de pacientes > 60 años con quejas subjetivas de memoria y/o deterioro cognitivo de al menos 6 meses de evolución.
Diseño
Estudio observacional, longitudinal, multicéntrico y naturalístico, con un período de seguimiento de 12 meses.
Emplazamiento
Un total de 105 centros de atención primaria.
Participantes
Participaron 921 pacientes que acudieron a consulta.
Mediciones principales
En la visita basal se recogieron las características sociodemográficas, el diagnóstico, el tratamiento y las derivaciones asistenciales, y en las 2 siguientes (6 y 12 meses), el cambio de diagnóstico, el tratamiento y las derivaciones.
Resultados
El 66,9% de los sujetos eran mujeres y la edad media fue de 74,3 ± 6,8 años. En la visita inicial, el 50,5% (intervalo de confianza [IC] del 95%, 47,3-53,7) de los diagnósticos fue de tipo sindrómico y el 33,3% (IC del 95%, 30,3-36,3), etiológico. El médico de atención primaria modificó el diagnóstico de sospecha inicial en el 22% (IC del 95%, 19,3-24,7) de los pacientes durante el año de seguimiento del estudio. El 63,8% (IC del 95%, 60,7-66,9) de los pacientes fue diagnosticado a través de la anamnesis, la exploración física, el test de cribado y los datos de laboratorio. En la visita inicial, el 52,6% (IC del 95%, 49,4-55,8) de los pacientes recibían tratamiento, principalmente nootropos y neuroprotectores, y más tarde aumentó el porcentaje de pacientes con inhibidores de la colinesterasa. Durante los 12 meses de estudio, el médico de atención primaria remitió a un 54,9% (IC del 95%, 51,7-58,1) de los pacientes.
Conclusiones
El médico de atención primaria diagnostica a la mayoría de los pacientes con los medios disponibles, basándose fundamentalmente en la anamnesis, la exploración, el test de cribado y los datos de laboratorio. Se prescriben fármacos que carecen de eficacia en esta enfermedad y pocos de los que han demostrado eficacia.
Palabras clave: Deterioro cognitivo, Quejas de memoria, Tratamiento clínico
Abstract
Objective
To describe the initial treatment of patients >60 years who had subjective memory complaints and/or cognitive impairment for at least 6 months.
Design
Observational, longitudinal, multicentre, and naturalistic study, with a follow-up period of 12 months.
Setting
A total of 105 primary care centres.
Participants
The study included 921 patients who attended a clinic.
Main measurements
In the baseline visit, the social demographic characteristics, diagnosis, treatment, and the health care referrals were recorded, and in the next 2 (6 and 12 months) the diagnostic change, treatment, and referrals.
Results
The majority of subjects were female (66.9%) and the mean age was 74.3 ± 6.8 years. In the initial visit, 50.5% (95% confidence interval [CI], 47.3-53.7) of the diagnoses were classed as syndromic and 33.3% (95% CI, 30.3-36.3), aetiological.
The primary care doctor modified an unconfirmed initial diagnosis in 22% (95% CI, 19.3-24.7) of the patients during the 12 months follow-up study. A diagnosis was made in 63.8% (95% CI, 60.7-66.9) of patients by anamnesis, physical examination, the screening test, and laboratory data. In the initial visit, el 52.6% (95% CI, 49.4-55.8) received treatment of mainly nootropics and neuroprotectors, and later, the percentage of patients on cholinesterase inhibitors increased. The primary care doctor referred 54.9% (95% CI, 51.7-58.1) of the patients during the 12 months of the study.
Conclusions
The primary care doctor diagnoses the majority of patients with the means available, mainly based on anamnesis, examination, the screening test, and laboratory data. They prescribe drugs that lack efficacy for this disease and few of those that have been shown to be effective.
Key words: Cognitive impairment, Memory complaints, Clinical treatment
Bibliografía
- 1.Zunzunegui M.V., Del Ser T., Rodríguez Laso A., García Yébenes M.J., Domingo J., Otero Puime A. Demencia no detectada y utilización de los servicios sanitarios: implicaciones para la atención primaria. Aten Primaria. 2003;31:581–586. doi: 10.1016/S0212-6567(03)79220-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Plan Nacional de Atención a los Enfermos de Alzheimer y otras demencias. 1999/2005. Segundo borrador. Madrid: Ministerio de Asuntos Sociales; 2005.
- 3.Boustani M., Peterson B., Hanson L., Harris R., Lohr K.N. Screening for dementia in primary care: a summary of the evidence for the US Preventive Services Task Force. Ann Intern Med. 2003;138:927–937. doi: 10.7326/0003-4819-138-11-200306030-00015. [DOI] [PubMed] [Google Scholar]
- 4.Kawas C.H. Early Alzheimer's disease. N Engl J Med. 2003;349:1056–1063. doi: 10.1056/NEJMcp022295. [DOI] [PubMed] [Google Scholar]
- 5.Santacruz K.S., Swagerty D. Early diagnosis of dementia. Am Fam Physician. 2001;63:703–713. [PubMed] [Google Scholar]
- 6.Woods R.T., Moniz-Cook E., Lliffe S., Campion P. Dementia: issues in early recognition and intervention in primary care. J R Soc Med. 2003;96:320–324. doi: 10.1258/jrsm.96.7.320. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Löppönen M., Räihä I., Isoaho R., Vahlberg T., Kivelä S. Diagnosing cognitive impairment and dementia in primary health carea more active approach is needed. Age Ageing. 2003;32:606–612. doi: 10.1093/ageing/afg097. [DOI] [PubMed] [Google Scholar]
- 8.Olafsdóttir M., Foldevi M., Marcusson J. Dementia in primary care: why the low detection rate? Scand J Prim care. 2001;19:194–198. doi: 10.1080/028134301316982469. [DOI] [PubMed] [Google Scholar]
- 9.Valcour V.G., Masaki K.H., Curb D., Lanoie-Blanchette P. The detection of dementia in the primary care setting. Arch Intern Med. 2000;160:2964–2968. doi: 10.1001/archinte.160.19.2964. [DOI] [PubMed] [Google Scholar]
- 10.López-Pousa S., Vilalta-Franch J., Llinas-Regla J., Garre-Olmo J., Roman G.C. Incidence of dementia in a rural community in Spain: the Girona cohort study. Neuroepidemiology. 2004;23:170–177. doi: 10.1159/000078502. [DOI] [PubMed] [Google Scholar]
- 11.Roca W.A. Dementia, Parkinson's disease and stroke in Europe: a commentary. Neurology. 2000;54(Suppl 5):538–540. [PubMed] [Google Scholar]
- 12.Ferry C.P., Prince M., Brayne C., Brodaty H., Fratiglioni L., Ganguli M. Global prevalence of dementia: a Delphi consensus study. Lancet. 2005;366:2112–2117. doi: 10.1016/S0140-6736(05)67889-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Villar A, Molinuevo Guix JL, Gómez-Isla T. Enfermedad de Alzheimer. Jano. 2004;LXVII:28-32.
- 14.Casabella B., Espinàs J., Álvarez M., Fernández J.A., Font C., García F. Edide; Barcelona: 1999. Demencias. Recomendaciones semFYC. [Google Scholar]
- 15.Jonker C., Geerlings M.I., Schmand B. Are memory complaints predictive for dementia? A review of clinical and population-based studies. Int J Geriatr Psychiatry. 2000;15:983–991. doi: 10.1002/1099-1166(200011)15:11<983::aid-gps238>3.0.co;2-5. [DOI] [PubMed] [Google Scholar]
- 16.American Psychiatric Association. Diagnostic and statitiscal manual of mental disorders. 4th ed. (DSM-IV). Washington, DC: American Psychiatric Association; 1994.
- 17.Román G.C., Tatemichi T.K., Erkinjuntti T., Cummings J.L., Masdeu J.C., García J.H. Vascular dementia: diagnostic criteria for research studies. Report of the NINCDS-AIREN International Workshop. Neurology. 1993;43:250–261. doi: 10.1212/wnl.43.2.250. [DOI] [PubMed] [Google Scholar]
- 18.McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease. Report of the NINCDS-ADRDA work group under the auspices of the Department of Health & Human Services Task Force on Alzheimer's disease. Neurology. 1984;34:939–944. doi: 10.1212/wnl.34.7.939. [DOI] [PubMed] [Google Scholar]
- 19.Petersen R., Smith G., Waring S., Ivnik R., Tangalos E., Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56:303–308. doi: 10.1001/archneur.56.3.303. [DOI] [PubMed] [Google Scholar]
- 20.Burns A., Jacoby R., Levy R. Psychiatric disorders in Alzheimer's disease III: disorders of mood. Br J Psychiatry. 1990;157:81–94. doi: 10.1192/bjp.157.1.81. [DOI] [PubMed] [Google Scholar]
- 21.Audit Comisión. Forget Me Not 2002: Developing Mental Health Services for Older People in England. London: Audit Commission, 2002.
- 22.Löppönen M., Räihä I., Isoaho R., Vahlberg T., Kivelä S. Diagnosing cognitive impairment and dementia in primary health care-a more active approach is needed. Age Ageing. 2003;32:606–612. doi: 10.1093/ageing/afg097. [DOI] [PubMed] [Google Scholar]
- 23.Moliner C., Martínez J., Gené J., Lazorla M.E., Herrera A., Rozas M. Estudio preliminar de demencia en atención primaria. Aten Primaria. 1999;24:169–174. [PubMed] [Google Scholar]
- 24.Puente A., Ribas A., Salla R.M., Parrilla L., Espinás J., Caballé E. Las demencias en el ámbito de la atención primaria. Aten Primaria. 1997;19:419–422. [PubMed] [Google Scholar]
- 25.Clarfield A.M. The reversible dementias: do they reverse? Ann Intern Med. 1988;109:476–486. doi: 10.7326/0003-4819-109-6-476. [DOI] [PubMed] [Google Scholar]
- 26.Boada M., Peña-Casanova J., Bermejo F., Guillén F., Hart W.M., Espinosa C. Coste de los recursos sanitarios de los pacientes en régimen ambulatorio diagnosticados de enfermedad de Alzheimer en España. Med Clin (Barc) 1999;113:690–695. [PubMed] [Google Scholar]
- 27.Cummings J.L., Schneider L., Tariot P.N., Kershaw Pr., Yuan W. Reduction of behavioural disturbances and caregiver distress by galantamine in patients with Alzheimer's disease. Am J Psychiatry. 2004;161:532–538. doi: 10.1176/appi.ajp.161.3.532. [DOI] [PubMed] [Google Scholar]
- 28.Doraiswamy P.M., Krishnan K.R., Anand R., Sohn H., Danyluk J., Hartman R.D. Long-term effects of rivastigmine in moderately severe Alzheimer's disease: does early initiation of therapy offer sustained benefits? Prog Neuropsychopharmacol Biol Psychiatry. 2002;26:705–712. doi: 10.1016/s0278-5846(01)00326-8. [DOI] [PubMed] [Google Scholar]
- 29.Solomon P.R., Brush M., Calvo V., Adams F., De Veaux R.D., Pendlebury W.P. Identifying dementia in the primary care practice. Int Psychogeriatr. 2000;12:483–493. doi: 10.1017/s1041610200006608. [DOI] [PubMed] [Google Scholar]
- 30.De Lepeleire J., Aergeerts B., Umback I. The diagnostic value of IADL evaluation in the detection of dementia in general practice. Aging Ment Health. 2004;8:62–67. doi: 10.1080/13607860310001613338. [DOI] [PubMed] [Google Scholar]
- 31.Verhey F.R., Jolles J., Ponds R.W., Rozendaal N., Plugge L.A., De Vet R.C. Diagnosing dementia: a comparison between a monodisciplinary and a multidisciplinary approach. J Neuropsychiatry Clin Neurosci. 1993;5:78–85. doi: 10.1176/jnp.5.1.78. [DOI] [PubMed] [Google Scholar]
- 32.Woods R.T., Moniz-Cook E., Iliffe S., Campion P., Vernooij-Dassen M., Zanetti O. Dementia: issues in early recognition and intervention in primary care. JR Soc Med. 2003;96:320–324. doi: 10.1258/jrsm.96.7.320. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Frisoni G.R. Treatment of Alzheimer's disease with acetylcholinesterase inhibitors: bridging the gap between evidence and practice. J Neurol. 2001;241:551–557. doi: 10.1007/s004150170131. [DOI] [PubMed] [Google Scholar]
- 34.Badia Llach X., Lizan Tudela L. Investigación de resultados en salud. Aten Primaria. 2002;30:388–391. doi: 10.1016/S0212-6567(02)79052-5. [DOI] [PMC free article] [PubMed] [Google Scholar]